Figure 1.

Modeled^a percentage and 95% confidence intervals of adults categorized as intermediate/high^b or high CVD risk by time in relation to Roux-en-Y gastric bypass, stratified by sex.

Abbreviations: ASCVD, Atherosclerotic cardiovascular disease; BMI, Body Mass Index (kg/m2); CVD, cardiovascular disease.

^a Adjusted for factors related to missing follow-up data (i.e. site, age and current smoking status at pre-surgery). All pairwise comparison tests (for pre-surgery vs 1 year, 1 year vs 7 years and pre-surgery vs 7 years) were significant (p ≤0.01) with the exception of 1 year vs 7 years 10-year ASCVD (p=0.14) and lifetime Framingham-lipids (p=0.12) in females, and the 10-year ASCVD in males (p=0.08).

^b Because the Framingham intermediate risk category can be used to initiate statin therapy, the Framingham intermediate and high risk groups were combined.

^c Data collection ended before the 7 year assessment of 316 females and 71 males.